Roldán-González E, Gómez-Rodríguez F J, Jácome-Velasco S J, Riascos-Forero Y, Rosas-Roldán L A, Hurtado-Otero M L, Sarria-Gómez A V
Fundación Universitaria María Cano sede Popayán, Popayán, Colombia.
Universidad del Cauca, Popayán, Colombia.
Rev Neurol. 2024 Jul 16;79(2):41-49. doi: 10.33588/rn.7902.2024093.
The increase in the number of people with upper limb spasticity as a sequela of cerebrovascular disease, which negatively impacts their autonomy, functional independence and participation, and affects their quality of life, calls for the application of precise and objective instruments for its measurement and evaluation.
To assess the validity and reliability of the Tardieu scale in the evaluation of upper extremity spasticity in adults with cerebrovascular disease.
The search strategy was implemented in eight databases; the systematic review protocol was registered beforehand in INPLASY (with registration no. 2023110076). The evidence was synthesised in three phases: a tabular presentation of results, an evaluation of the quality of the articles, and a narrative synthesis of the findings.
Only three of the 33 articles identified fulfilled the variables that enable the validity and reliability of the Tardieu scale to be established. The measurements of angles and velocities R1, R2 and R2-R1 were analysed. Student's t-test to assess the reliability between the measurements of R1 and R2; and angles R2 and R2-R1 showed statistical significance, which confirmed the reliability of the scale.
The Tardieu scale proved robust. It is important to note that the sample size, the time of evolution of the disease and the age of the patients may influence the results of the scale.
作为脑血管疾病后遗症的上肢痉挛患者数量不断增加，这对他们的自主性、功能独立性和参与度产生了负面影响，进而影响他们的生活质量，因此需要应用精确客观的工具来进行测量和评估。
评估Tardieu量表在评估脑血管疾病成年患者上肢痉挛方面的有效性和可靠性。
在八个数据库中实施检索策略；系统评价方案事先在INPLASY注册（注册号为2023110076）。证据综合分为三个阶段：结果的表格呈现、文章质量评估以及研究结果的叙述性综合。
在检索到的33篇文章中，只有3篇满足能够确定Tardieu量表有效性和可靠性的变量。分析了角度和速度R1、R2以及R2-R1的测量结果。采用学生t检验评估R1和R2测量值之间以及角度R2和R2-R1之间的可靠性，结果显示具有统计学意义，这证实了该量表的可靠性。
Tardieu量表被证明是可靠的。需要注意的是，样本量、疾病进展时间和患者年龄可能会影响该量表的结果。
